Did you know?

hear from you. To get technical support, learn more about our product, or for any other reason, contact us directly or send us a message and we will respond promptly. [email protected]. Study Design A randomized, double-blind, parallel-group, 4-week, controlled trial of AKL-T01* in children aged 8-12 years old with ADHD (not taking ADHD medications) and TOVA API baseline scores of ≤ −1.8, conducted at 20 sites in the USA. 348 subjects were randomly assigned to receive AKL-T01 (n=180) or control (n=168) for approximately 25 minutes perRead More »STARS-ADHD Pivotal Study EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-17 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of ... Study Design. An open label single arm 6 week trial of AKL-T01 in adults. 18 years and older, with ADHD, primarily inattentive or combined-type ADHD (either on or off ADHD medication) with a TOVA ACS baseline score ≤ -1.8, conducted at 14 sites in the USA. The 221 participants were asked to engage with the treatment for approximately 25 ... Parents can enroll online with a phone in a matter of minutes. 1. Akili will validate and process the order submitted. 2. Parent receives an email with a link to pay for treatment. 3. Once payment is complete a follow up email is sent with a unique activation code. 4. Parent downloads the app and activates treatment using the code. The STARS-ADHD Adolescent study used to generate data to support AKL-T01* enrolled 162 adolescents ages 13-17 with ADHD for a four week treatment period. Study Design An open label single arm 4 week trial of AKL-T01 in adolescents ages 13-17 with ADHD (either on or off ADHD medication) with a TOVA ACS baseline score ≤ -1.8. Read More »STARS-ADHD Adolescent EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-17 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of ... Dec 20, 2023 · Managing ADHD symptoms can feel like navigating a maze without a map. The unpredictability of life, coupled with the challenges posed by ADHD, can make even the simplest tasks seem daunting. However, it’s possible to channel all this into productive avenues with the right strategies and a proactive approach. Whether you’re seeking ways to manageRead More »How to Manage Your ADHD Symptoms Jan 22, 2024 · Share: We built EndeavorOTC to help people improve their ADHD symptoms naturally. Based on our data, users report a reduction in their symptoms after around four to six weeks of using the treatment, but that doesn’t mean treatment isn’t working more quickly. To demonstrate EndeavorOTC’s impact, our data science, cognitive science, and ... The Focus Score measures how quickly and accurately you can complete a task despite distractions during EndeavorOTC treatment. The goal is to give you an easy way to track your focus improvement from your baseline Focus Score. At the start of treatment, we’ll provide you with a personalized target score. Jun 7, 2023 · Akili’s Endeavor suite of products, EndeavorOTC and EndeavorRx, combine the best of medicine and mobile gaming and were developed through the collaboration of world-renowned cognitive neuroscientists and acclaimed entertainment and technology designers. The STARS-ADHD Adolescent study used to generate data to support AKL-T01* enrolled 162 adolescents ages 13-17 with ADHD for a four week treatment period. Study Design An open label single arm 4 week trial of AKL-T01 in adolescents ages 13-17 with ADHD (either on or off ADHD medication) with a TOVA ACS baseline score ≤ -1.8. Read More »STARS-ADHD Adolescent Study Design A randomized, double-blind, parallel-group, 4-week, controlled trial of AKL-T01* in children aged 8-12 years old with ADHD (not taking ADHD medications) and TOVA API baseline scores of ≤ −1.8, conducted at 20 sites in the USA. 348 subjects were randomly assigned to receive AKL-T01 (n=180) or control (n=168) for approximately 25 minutes perRead More »STARS-ADHD Pivotal Study

Parents can enroll online with a phone in a matter of minutes. 1. Akili will validate and process the order submitted. 2. Parent receives an email with a link to pay for treatment. 3. Once payment is complete a follow up email is sent with a unique activation code. 4. Parent downloads the app and activates treatment using the code. Study Design. An open label single arm 6 week trial of AKL-T01 in adults. 18 years and older, with ADHD, primarily inattentive or combined-type ADHD (either on or off ADHD medication) with a TOVA ACS baseline score ≤ -1.8, conducted at 14 sites in the USA. The 221 participants were asked to engage with the treatment for approximately 25 ... Feb 7, 2024 · EndeavorOTC is a product built by parent company Akili – the same company that created EndeavorRx, the world’s first FDA–authorized prescription video game treatment for pediatric ADHD. As a digital therapeutic, EndeavorOTC was built by neuroscientists, cognitive scientists, clinical psychologists, and other healthcare professionals. Version 2.5.0 and higher: EndeavorOTC Instructions for Use. Revision I. View and download. Version 2.4.0 and higher: EndeavorOTC Instructions for Use. Revision H. View and download. Version 2.3.0 and higher: EndeavorOTC Instructions for Use. Revision G. View and download.

Feb 5, 2024 · Medical Treatments for Adult ADHD: Comparing Stimulants, Behavioral Therapy, and Digital Therapeutics. By Dr. Caitlin Stamatis. February 5, 2024. ADHD Management. Share: A guide to medical treatments available to adults with ADHD, including cognitive-behavioral therapy, medication, and digital therapeutics. The Focus Score measures how quickly and accurately you can complete a task despite distractions during EndeavorOTC treatment. The goal is to give you an easy way to track your focus improvement from your baseline Focus Score. At the start of treatment, we’ll provide you with a personalized target score. Apr 16, 2024 · Another reason people seek novel medical treatments like digital therapeutics or DTx is that even the gold-standard treatments for ADHD (medication and behavioral therapy) have limitations, and for many, there are still bothersome symptoms that persist while using these treatments. Among our users, only 13% report good to excellent symptom ... …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. It costs $25 a month. Video game EndeavorOTC desig. Possible cause: Jun 7, 2023 · Akili’s Endeavor suite of products, EndeavorOTC and EndeavorRx, combine th.